CN8 AN ECONOMIC EVALUATION OF DASATINIB (SPRYCEL) IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) IN CENTRAL AND EASTERN EUROPE
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66231-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)66231-6/fulltext
Title :
CN8 AN ECONOMIC EVALUATION OF DASATINIB (SPRYCEL) IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) IN CENTRAL AND EASTERN EUROPE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66231-6&doi=10.1016/S1098-3015(10)66231-6
First page :
Section Title :
Open access? :
No
Section Order :
66